Cumberland Pharmaceuticals (CPIX) reported third-quarter 2026 total revenue of $2.2 million and net income of $77.8 million, including a gain from the disposal of discontinued operations associated with its Strategic Transaction with Apotex Health.
The company said it plans to submit a New Drug Application to the FDA for ifetroban for cardiomyopathy associated with Duchenne muscular dystrophy and announced top-line results from its Phase 2a systemic sclerosis study.
- Total revenue was $2.16 million for the quarter ended September 30, 2026.
- Net income was $77.78 million, or $5.19 per basic share and $5.07 per diluted share.
- Net income from discontinued operations was $78.90 million, including an $81.09 million gain on disposal.
- Cash and cash equivalents totaled $80.6 million as of September 30, 2026.
- Total assets were $113.8 million and total liabilities were $41.6 million at quarter-end.
- The FDA granted rolling review for Cumberland's planned ifetroban NDA submission in DMD cardiomyopathy.
$CPIX Hedge Fund Activity
We have seen 15 institutional investors add shares of $CPIX stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DIVERSIFIED TRUST CO added 700,000 shares (+inf%) to their portfolio in Q3 2026, for an estimated $5,481,000
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 137,268 shares (-84.0%) from their portfolio in Q2 2026, for an estimated $889,496
- PERCEPTIVE ADVISORS LLC removed 99,996 shares (-50.8%) from their portfolio in Q2 2026, for an estimated $647,974
- J. GOLDMAN & CO LP removed 81,040 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $525,139
- SEI INVESTMENTS CO added 57,308 shares (+inf%) to their portfolio in Q3 2026, for an estimated $448,721
- IKARIAN CAPITAL, LLC removed 50,000 shares (-9.0%) from their portfolio in Q2 2026, for an estimated $324,000
- DIMENSIONAL FUND ADVISORS LP removed 49,291 shares (-21.1%) from their portfolio in Q3 2026, for an estimated $385,948
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
